“North America crop protection chemicals market is anticipated to grow at a CAGR of over 5% from 2020 to 2030”, says Visiongain

29 November 2019
Pharma

Visiongain’s new report North America Crop Protection Chemicals Market 2020-2030: Forecasts by Type (Pesticides, Synthetic Pesticides, Biopesticides, Adjuvants), Crop Type (Cereals & Grains, Oil Seeds, Fruits & Vegetables, Others), by region and analysis of leading companies operating in this industry.

North America crop protection chemicals market was valued at over USD 15 billion in 2018 and is anticipated to grow at a CAGR of over 5% during the forecast period from 2020 to 2030. Pesticides also are known as crop defense chemicals are a class of agrochemicals used to destroy plant-harming species such as insects, rodents, weeds, nematodes, etc. and to avoid crop damage by them. Pesticide can be called any substance or combination that can avoid, kill, repel or reduce an insect. Pesticides are classified as herbicides, insecticides, insect growth regulators, nematicides, molluscicides, termiticides, avicides, piscicides, predacides, rodenticides, bactericides, repellents for insects, and animals, antimicrobials, fungicides, disinfectants, sanitizers and their bio counters.

The demand for pesticides is motivated by the need to increase crop yields and production. The population of the area is increasing, but the farmlands are declining to force farmers to increase their yields. Farmers are adopting new farming practices to increase crop yields. Genetically modified (GM) crops have enabled farmers in some pesticides to increase their yields, combined with reduced use. The adoption of bio-pesticides is also taking place throughout the world, especially in developed and developing countries.

Traditionally, North America has been a large producer of chemicals for plant safety. Nonetheless, in recent years, the EPA and USDA-controlled regulatory framework have become increasingly restrictive on pesticide registration and advertising. Arable land has been decreasing since 2005 due to the growing demand for animal feed and increased use of corn for renewable chemicals and biofuels.

Revenue growth is expected to be higher than volume due to rising pesticide costs. The U.S. is North America's most dominant market, accounting for more than 80% of North America's total demand for plant defense chemicals in 2010. Due to the expansion of farmland and the growing use of pesticides, Brazil's plant protection chemicals market is moving rapidly to become the most attractive growth market for chemical crop protection companies.

North America's demand for plant protection chemicals dominates the international herbicide industry and has the highest volume and revenue market share. Europe is the second-largest herbicide market. North America is a mature market with a few major players dominating it. Industries in this area are focused on new product development to withstand intense competition.

The demand for chemicals for plant safety in North America was split into patented and generic pesticides. About more than 67% of the market share belongs to exclusive and proprietary active ingredients, while 33% of this segment is generic. The proprietary market for pesticides was developed with a strong focus on North American plant protection chemicals based on strict regulations regulated by U.S. and European standards. In such circumstances, most of the major global players are focused on reducing their low-income ($million) off-patent proprietary goods production capacity.

Some of the key Crop Protection Chemicals market players include Arysta LifeScience, American Vanguard, Bayer CropScience, BioWorks, BASF SE, Chemtura Corp, Cheminova, Chr Hansen, Dow AgroSciences, DuPont, FMC Corp, Ishihara Sangyo Kaisha, Isagro SpA, Makhteshim Agan, Monsanto, Natural Industries, Marrone Bio Innovations, Nufarm Ltd, Novozymes A/S, Syngenta AG among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever